Report Detail
Global Ophthalmic Biologics Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4673910 |
- 18 February, 2026 |
- Global |
- 92 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Ophthalmic Biologics market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global Ophthalmic Biologics market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Ophthalmic Biologics market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Ophthalmic Biologics market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Ophthalmic Biologics market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Ophthalmic Biologics market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Ophthalmic Biologics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Ophthalmic Biologics market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, Novartis, Bayer, Genentech, Apellis Pharmaceuticals, Inc., Coherus BioSciences Inc., Iveric Bio, Regeneron, Qilu Pharmaceutical Co.,Ltd., Chengdu Kanghong Pharmaceutical Group, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Ophthalmic Biologics market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Ranibizumab
Bevacizumab
Aflibercept
Brolucizumab
Faricimab
Others
Market segment by Application
Age-related Macular Degeneration Treatment
Diabetic Retinopathy Treatment
Inhibit Abnormal Angiogenesis
Major players covered
Sanofi
Novartis
Bayer
Genentech
Apellis Pharmaceuticals, Inc.
Coherus BioSciences Inc.
Iveric Bio
Regeneron
Qilu Pharmaceutical Co.,Ltd.
Chengdu Kanghong Pharmaceutical Group
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Ophthalmic Biologics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Ophthalmic Biologics, with price, sales quantity, revenue, and global market share of Ophthalmic Biologics from 2021 to 2026.
Chapter 3, the Ophthalmic Biologics competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ophthalmic Biologics breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Ophthalmic Biologics market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Ophthalmic Biologics.
Chapter 14 and 15, to describe Ophthalmic Biologics sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Ophthalmic Biologics Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Ranibizumab
- 1.3.3 Bevacizumab
- 1.3.4 Aflibercept
- 1.3.5 Brolucizumab
- 1.3.6 Faricimab
- 1.3.7 Others
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Ophthalmic Biologics Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Age-related Macular Degeneration Treatment
- 1.4.3 Diabetic Retinopathy Treatment
- 1.4.4 Inhibit Abnormal Angiogenesis
- 1.5 Global Ophthalmic Biologics Market Size & Forecast
- 1.5.1 Global Ophthalmic Biologics Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Ophthalmic Biologics Sales Quantity (2021-2032)
- 1.5.3 Global Ophthalmic Biologics Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Sanofi
- 2.1.1 Sanofi Details
- 2.1.2 Sanofi Major Business
- 2.1.3 Sanofi Ophthalmic Biologics Product and Services
- 2.1.4 Sanofi Ophthalmic Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Sanofi Recent Developments/Updates
- 2.2 Novartis
- 2.2.1 Novartis Details
- 2.2.2 Novartis Major Business
- 2.2.3 Novartis Ophthalmic Biologics Product and Services
- 2.2.4 Novartis Ophthalmic Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Novartis Recent Developments/Updates
- 2.3 Bayer
- 2.3.1 Bayer Details
- 2.3.2 Bayer Major Business
- 2.3.3 Bayer Ophthalmic Biologics Product and Services
- 2.3.4 Bayer Ophthalmic Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Bayer Recent Developments/Updates
- 2.4 Genentech
- 2.4.1 Genentech Details
- 2.4.2 Genentech Major Business
- 2.4.3 Genentech Ophthalmic Biologics Product and Services
- 2.4.4 Genentech Ophthalmic Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Genentech Recent Developments/Updates
- 2.5 Apellis Pharmaceuticals, Inc.
- 2.5.1 Apellis Pharmaceuticals, Inc. Details
- 2.5.2 Apellis Pharmaceuticals, Inc. Major Business
- 2.5.3 Apellis Pharmaceuticals, Inc. Ophthalmic Biologics Product and Services
- 2.5.4 Apellis Pharmaceuticals, Inc. Ophthalmic Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Apellis Pharmaceuticals, Inc. Recent Developments/Updates
- 2.6 Coherus BioSciences Inc.
- 2.6.1 Coherus BioSciences Inc. Details
- 2.6.2 Coherus BioSciences Inc. Major Business
- 2.6.3 Coherus BioSciences Inc. Ophthalmic Biologics Product and Services
- 2.6.4 Coherus BioSciences Inc. Ophthalmic Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Coherus BioSciences Inc. Recent Developments/Updates
- 2.7 Iveric Bio
- 2.7.1 Iveric Bio Details
- 2.7.2 Iveric Bio Major Business
- 2.7.3 Iveric Bio Ophthalmic Biologics Product and Services
- 2.7.4 Iveric Bio Ophthalmic Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Iveric Bio Recent Developments/Updates
- 2.8 Regeneron
- 2.8.1 Regeneron Details
- 2.8.2 Regeneron Major Business
- 2.8.3 Regeneron Ophthalmic Biologics Product and Services
- 2.8.4 Regeneron Ophthalmic Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Regeneron Recent Developments/Updates
- 2.9 Qilu Pharmaceutical Co.,Ltd.
- 2.9.1 Qilu Pharmaceutical Co.,Ltd. Details
- 2.9.2 Qilu Pharmaceutical Co.,Ltd. Major Business
- 2.9.3 Qilu Pharmaceutical Co.,Ltd. Ophthalmic Biologics Product and Services
- 2.9.4 Qilu Pharmaceutical Co.,Ltd. Ophthalmic Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 Qilu Pharmaceutical Co.,Ltd. Recent Developments/Updates
- 2.10 Chengdu Kanghong Pharmaceutical Group
- 2.10.1 Chengdu Kanghong Pharmaceutical Group Details
- 2.10.2 Chengdu Kanghong Pharmaceutical Group Major Business
- 2.10.3 Chengdu Kanghong Pharmaceutical Group Ophthalmic Biologics Product and Services
- 2.10.4 Chengdu Kanghong Pharmaceutical Group Ophthalmic Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 Chengdu Kanghong Pharmaceutical Group Recent Developments/Updates
3 Competitive Environment: Ophthalmic Biologics by Manufacturer
- 3.1 Global Ophthalmic Biologics Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Ophthalmic Biologics Revenue by Manufacturer (2021-2026)
- 3.3 Global Ophthalmic Biologics Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Ophthalmic Biologics by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Ophthalmic Biologics Manufacturer Market Share in 2025
- 3.4.3 Top 6 Ophthalmic Biologics Manufacturer Market Share in 2025
- 3.5 Ophthalmic Biologics Market: Overall Company Footprint Analysis
- 3.5.1 Ophthalmic Biologics Market: Region Footprint
- 3.5.2 Ophthalmic Biologics Market: Company Product Type Footprint
- 3.5.3 Ophthalmic Biologics Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Ophthalmic Biologics Market Size by Region
- 4.1.1 Global Ophthalmic Biologics Sales Quantity by Region (2021-2032)
- 4.1.2 Global Ophthalmic Biologics Consumption Value by Region (2021-2032)
- 4.1.3 Global Ophthalmic Biologics Average Price by Region (2021-2032)
- 4.2 North America Ophthalmic Biologics Consumption Value (2021-2032)
- 4.3 Europe Ophthalmic Biologics Consumption Value (2021-2032)
- 4.4 Asia-Pacific Ophthalmic Biologics Consumption Value (2021-2032)
- 4.5 South America Ophthalmic Biologics Consumption Value (2021-2032)
- 4.6 Middle East & Africa Ophthalmic Biologics Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Ophthalmic Biologics Sales Quantity by Type (2021-2032)
- 5.2 Global Ophthalmic Biologics Consumption Value by Type (2021-2032)
- 5.3 Global Ophthalmic Biologics Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Ophthalmic Biologics Sales Quantity by Application (2021-2032)
- 6.2 Global Ophthalmic Biologics Consumption Value by Application (2021-2032)
- 6.3 Global Ophthalmic Biologics Average Price by Application (2021-2032)
7 North America
- 7.1 North America Ophthalmic Biologics Sales Quantity by Type (2021-2032)
- 7.2 North America Ophthalmic Biologics Sales Quantity by Application (2021-2032)
- 7.3 North America Ophthalmic Biologics Market Size by Country
- 7.3.1 North America Ophthalmic Biologics Sales Quantity by Country (2021-2032)
- 7.3.2 North America Ophthalmic Biologics Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Ophthalmic Biologics Sales Quantity by Type (2021-2032)
- 8.2 Europe Ophthalmic Biologics Sales Quantity by Application (2021-2032)
- 8.3 Europe Ophthalmic Biologics Market Size by Country
- 8.3.1 Europe Ophthalmic Biologics Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Ophthalmic Biologics Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Ophthalmic Biologics Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Ophthalmic Biologics Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Ophthalmic Biologics Market Size by Region
- 9.3.1 Asia-Pacific Ophthalmic Biologics Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Ophthalmic Biologics Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Ophthalmic Biologics Sales Quantity by Type (2021-2032)
- 10.2 South America Ophthalmic Biologics Sales Quantity by Application (2021-2032)
- 10.3 South America Ophthalmic Biologics Market Size by Country
- 10.3.1 South America Ophthalmic Biologics Sales Quantity by Country (2021-2032)
- 10.3.2 South America Ophthalmic Biologics Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Ophthalmic Biologics Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Ophthalmic Biologics Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Ophthalmic Biologics Market Size by Country
- 11.3.1 Middle East & Africa Ophthalmic Biologics Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Ophthalmic Biologics Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Ophthalmic Biologics Market Drivers
- 12.2 Ophthalmic Biologics Market Restraints
- 12.3 Ophthalmic Biologics Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Ophthalmic Biologics and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Ophthalmic Biologics
- 13.3 Ophthalmic Biologics Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Ophthalmic Biologics Typical Distributors
- 14.3 Ophthalmic Biologics Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Ophthalmic Biologics. Industry analysis & Market Report on Ophthalmic Biologics is a syndicated market report, published as Global Ophthalmic Biologics Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Ophthalmic Biologics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
